grant

Defining Immune Dysfunction in Chronic Hepacivirus Infection at Single Cell Resolution

Organization ICAHN SCHOOL OF MEDICINE AT MOUNT SINAILocation NEW YORK, UNITED STATESPosted 1 Aug 2024Deadline 31 Jul 2027
NIHUS FederalResearch GrantFY2025AffectAnimal ModelAnimal Models and Related StudiesAnimalsAnti-viral AgentsAntigen-Antibody ComplexAntigensAtlasesCD8CD8BCD8B1CD8B1 geneCITE sequencingCITE-seqCITEseqCell BodyCell LineageCellsCellular Indexing of Transcriptomes and Epitopes by SequencingCharacteristicsChronicChronic Hepatitis CChronic type C viral hepatitisChronic viral hepatitisChronic viral hepatitis CCommon Rat StrainsComplexDataDevelopmentDiseaseDisorderDysfunctionEnvironmentEvolutionFoundationsFunctional disorderGene Action RegulationGene ExpressionGene Expression RegulationGene RegulationGene Regulation ProcessGene TranscriptionGeneralized GrowthGenesGenetic TranscriptionGoalsGrowthHCVHCV infectionHealthHepacivirusHepaticHepatic CancerHepatic DisorderHepatitis C virusHepatitis C virus infectionHepatitis C-Like VirusesHepatocarcinomaHepatocellular CarcinomaHepatocellular cancerHepatomaHumanImmuneImmune ComplexImmune DiseasesImmune DisordersImmune DysfunctionImmune System DiseasesImmune System DisorderImmune System DysfunctionImmune System and Related DisordersImmune infiltratesImmune responseImmunesImmunochemical ImmunologicImmunocompetentImmunologicImmunologic DiseasesImmunologic TechnicsImmunologic TechniquesImmunologicalImmunological DiseasesImmunological DysfunctionImmunological System DysfunctionImmunological TechnicsImmunological TechniquesImmunologicallyImmunologicsImmunomodulationInfectionInflammationInvestigationKnowledgeLCM VirusesLCMVLYT3LiverLiver Cells CarcinomaLiver diseasesLong-term infectionLymphocytic choriomeningitis virusMaintenanceMalignant neoplasm of liverMentorshipMiceMice MammalsModelingModern ManMolecularMurineMusNatureNorway RatsPathologyPatientsPeptidesPersonsPhenotypePhysiologicPhysiologicalPhysiopathologyPlayPredispositionPreventative vaccinePreventive vaccinePrimary carcinoma of the liver cellsProphylactic vaccineRNA ExpressionRatRats MammalsRattusRattus norvegicusResearchResolutionRiskRisk FactorsRoleScientistSpecificityStudy modelsSusceptibilityT Cell SpecificityT cell receptor repertoire sequencingT cell receptor sequencingT cell responseT-Cell Immunologic SpecificityT-Cell SubsetsT-CellsT-LymphocyteT-Lymphocyte SubsetsTCR repertoire sequencingTCR sequencingTCR-seqTCRseqTechnologyTimeTissue GrowthTranscriptionViralViral AntigensViral DiseasesViral PathogenesisVirusVirus DiseasesWorkage associatedage correlatedage dependentage linkedage relatedage specificanti-viral compoundanti-viral drugsanti-viral medicationanti-viral therapeuticanti-viralsantigen-specific T cellscell typecellular indexing of transcriptomes and epitopes by single cell sequencingchronic HCV infectionchronic hepatitis C infectionchronic hepatitis C virus infectionchronic infectionchronic infections with HCVchronic infections with hepatitis C viruschronically infected with HCVchronically infected with hepatitis Cdevelopmentaldrug clearanceend stage liver diseaseend stage liver failureexhaustexhaustionhepatic body systemhepatic diseasehepatic organ systemhepatitis C infectionhepatopathyhost responseimmune cell infiltrateimmune competentimmune microenvironmentimmune modulationimmune regulationimmune system responseimmunogenimmunologic reactivity controlimmunomodulatoryimmunoregulationimmunoregulatoryimmunoresponseimmunosuppressive microenvironmentimmunosuppressive tumor microenvironmentinfected with HCVinfected with hepatitis Cinfected with hepatitis C virusinfection by hepatitis c virusinfection with HCVinfection with hepatitis Cinfection with hepatitis C virusliver cancerliver carcinomaliver disorderliver infectionliver malignancymalignant liver tumormodel of animalmouse modelmultiomicsmultiple omicsmurine modelnetwork modelsnovelontogenypanomicspathophysiologypersistent infectionpreventpreventingprogramsresolutionsresponsescRNA sequencingscRNA-seqsingle cell RNA-seqsingle cell RNAseqsingle cell expression profilingsingle cell transcriptomic profilingsingle-cell RNA sequencingsocial rolethymus derived lymphocytetraining opportunitytranscription regulatory networktranscriptomicstumor immune microenvironmenttumor-immune system interactionsviral infectionviral liver diseasevirus antigenvirus infectionvirus pathogenesisvirus-induced disease
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

PROJECT SUMMARY/ABSTRACT
Hepatitis C virus (HCV) is a hepacivirus that chronically infects an estimated 58 million people worldwide and

can result in end-stage liver disease. It has been well established that ineffectual T cell responses contribute to

the establishment and maintenance of chronic HCV infection. Namely, T cell exhaustion, wherein T cells lose

effector and proliferative functions due to chronic antigen stimulation, is a common phenomenon observed in

chronic HCV patients and is known to enable viral persistence. However, it has proven difficult to define

mechanistically different aspects of immune dysfunction in chronic hepacivirus infection, in part due to a lack of

animal models that can support chronic HCV infection and elicit a similar immune response. Norway rat

hepacivirus (NrHV) is a close relative of HCV that can establish chronic infection in immunocompetent mice and

recapitulate key features of chronic HCV, thus serving as a physiologically relevant and experimentally tractable

model for studying the immune response to chronic hepacivirus infection. Despite its promise as a model for

studying various aspects of the immune response to chronic hepacivirus infection, an in-depth characterization

of the immune landscape over time in chronic NrHV infection in mice has yet to be performed.

Here, I propose performing high-resolution immunological characterizations of this novel murine model of chronic

hepacivirus infection to study the evolution of immune dysfunction over the course of infection and to better

understand the molecular drivers of T cell exhaustion and viral persistence in chronic hepacivirus infection. First,

I will model transcriptional regulatory networks in chronic hepacivirus infection and other contexts of T cell

exhaustion to identify common and distinct transcriptional programs defining immune dysfunction (Aim 1). My

preliminary findings from existing transcriptomic data on this model suggest that there are two distinct lineages

of exhausted T cells in NrHV infection which may recognize viral antigen. Therefore, I will define the phenotypic

features of the two exhausted lineages in this model to elucidate the relationship between TCR specificity and

cellular phenotypes of virus-specific exhausted T cells (Aim 2). These studies are expected to ultimately

contribute to our understanding of the immunological mechanisms that drive T cell exhaustion, hinder hepacivirus

clearance, and contribute to the pathogenesis of viral liver disease in chronic HCV infection. The proposed

project provides an excellent training opportunity and environment that encompasses mastering cutting-edge

single cell and immunological techniques, professional development, and mentorship that support my goals and

growth as an independent research scientist.

Grant Number: 5F31AI186462-02
NIH Institute/Center: NIH

Principal Investigator: Tesia Bobrowski

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →